Cencora Inc’s recent filing unveils that its Executive Chairman COLLIS STEVEN H unloaded Company’s shares for reported $4.27 million on Jul 22 ’25. In the deal valued at $292.67 per share,14,578 shares were sold. As a result of this transaction, COLLIS STEVEN H now holds 309,913 shares worth roughly $89.99 million.
Then, Mauch Robert P. sold 4,968 shares, generating $1,461,138 in total proceeds. Upon selling the shares at $294.11, the President & CEO now owns 42,351 shares.
Before that, COLLIS STEVEN H bought 14,578 shares. Cencora Inc shares valued at $4,266,543 were divested by the Director at a price of $292.67 per share.
Wells Fargo upgraded its Cencora Inc [COR] rating to an Overweight from a an Equal weight in a research note published recently. BofA Securities also remained covering COR and has decreased its forecast on September 18, 2024 with a “Neutral” recommendation from previously “Buy” rating. Leerink Partners started covering the stock on February 26, 2024. It rated COR as “an Outperform”.
Price Performance Review of COR
On Friday, Cencora Inc [NYSE:COR] saw its stock fall -0.03% to $290.36. Over the last five days, the stock has lost -0.86%. Cencora Inc shares have risen nearly 29.47% since the year began. Nevertheless, the stocks have risen 29.23% over the past one year. While a 52-week high of $309.35 was reached on 05/07/25, a 52-week low of $218.65 was recorded on 01/02/25.
Levels Of Support And Resistance For COR Stock
The 24-hour chart illustrates a support level at 288.79, which if violated will result in even more drops to 287.22. On the upside, there is a resistance level at 292.54. A further resistance level may holdings at 294.71.
How much short interest is there in Cencora Inc?
A steep rise in short interest was recorded in Cencora Inc stocks on 2025-07-15, growing by 0.51 million shares to a total of 7.13 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 6.62 million shares. There was a rise of 7.11%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Overweight”‘ rating along with a $242 price target.
